Navigation Links
Prepared Remarks of Attorney General Michael B. Mukasey Before the House Judiciary Committee
Date:7/23/2008

WASHINGTON, July 23 /PRNewswire-USNewswire/ -- The following was released by the U.S. Department of Justice:

Chairman Conyers, Ranking Member Smith, and Members of the Committee. Thank you for the opportunity to testify today.

Since I appeared before this Committee almost six months ago, I have become even better acquainted with the talented and dedicated professionals at the Justice Department and with the work they do, and I have come to appreciate that much more deeply their service to our Nation.

I have now been Attorney General for slightly more than eight months. During that time, there have been moments of disagreement with Members of this Committee, as there always will be. There are policy initiatives that the Department supports that some of you vigorously oppose, and policy initiatives that some of you support that the Department opposes. There also are situations where the interests of the Executive Branch and the Legislature are in tension. This is not, as some people have suggested, evidence of a broken or flawed political system; it is part of the genius of the design of our Constitution, which embodies a robust separation of powers. Although these tensions will never disappear, there are many areas of agreement where we can work together on behalf of our common clients, the American people.

I would like to outline briefly two areas I will focus on during the six months remaining in this Administration.

First, with the first post-2001 transition looming, we must take every step to ensure that custody and responsibility for our Nation's security is transferred smoothly to a new set of caretakers. That means putting national security measures on a sound institutional footing so that the next Attorney General and the new Administration have in place what they need to continue to assure the nation's safety.

Two weeks ago, Congress took a vital step in passing the FISA Amendments Act of 2008, bipartisan legi
'/>"/>

SOURCE U.S. Department of Justice
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Deloitte and Nonprofit Roundtable Host Real-World Disaster Exercise as Next Step in Developing Preparedness Plan for Greater Washington Region
2. Statement from Eli Lilly and Company: Response to Connecticut Attorney General News Release
3. General Wesley Clark Joins Immtech as Consulting Strategic Advisor
4. Neupro(R) (Rotigotine Transdermal System) Effective in Controlling Early Morning Motor Impairment and Generally Well-Tolerated for Long-Term Use in Patients with Parkinsons Disease
5. Sugammadex Trials Demonstrate Rapid Recovery from Profound Neuromuscular Blockade During General Anesthesia
6. Ethics Group Asks USAID Inspector General to Investigate Legality of Grants to Soros Groups
7. Allegheny General Hospital Performs First Liver Transplant
8. First Clinical Volumetric Modulated Arc Therapy Treatment Completed With Elekta Synergy(R) S at General Hospital Vienna
9. Data Presented at AAN Show That Lacosamide Significantly Reduced Pain and was Generally Well Tolerated in Patients With Diabetic Neuropathic Pain
10. New CoMotion(R) Trials Software by General Dynamics Enables Rapid, Interactive Sharing of Real-time Data for Clinical Trials
11. New Data on SEROQUEL XR(TM) in Treatment of Both Major Depressive Disorder and Generalized Anxiety Disorder Presented at APA Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/28/2015)... , May 28, 2015  Eli Lilly and Company (NYSE: ... previously announced cash tender offer for up to $1.6 billion ... Holders of notes who tendered, and did not ... New York City time, on May 27, ... purchase by Lilly, are eligible to receive the total consideration. ...
(Date:5/28/2015)... May 28, 2015 /PRNewswire/ - ESSA Pharma Inc. ("ESSA" or ... second quarter and three and six months ended March 31, ... and in accordance with International Financial Reporting Standards ("IFRS"). ... net loss of $5.9 million ($0.35 per common share) for ... a net loss of $0.4 million ($0.03 per common share) ...
(Date:5/28/2015)... Research and Markets ( ... Jain PharmaBiotech,s new report  "RNAi - Technologies, ...      (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , , ... the use of double stranded RNA (dsRNA). ... processed into short 21-23 nucleotide RNAs termed ...
Breaking Medicine Technology:Lilly Announces the Pricing Terms of Its Cash Tender Offer for Up to $1.6 Billion Aggregate Principal Amount of Its Outstanding Debt Securities 2Lilly Announces the Pricing Terms of Its Cash Tender Offer for Up to $1.6 Billion Aggregate Principal Amount of Its Outstanding Debt Securities 3Lilly Announces the Pricing Terms of Its Cash Tender Offer for Up to $1.6 Billion Aggregate Principal Amount of Its Outstanding Debt Securities 4Lilly Announces the Pricing Terms of Its Cash Tender Offer for Up to $1.6 Billion Aggregate Principal Amount of Its Outstanding Debt Securities 5Essa Pharma Inc. Reports Second Quarter 2015 Financial Results 2Essa Pharma Inc. Reports Second Quarter 2015 Financial Results 3Essa Pharma Inc. Reports Second Quarter 2015 Financial Results 4Essa Pharma Inc. Reports Second Quarter 2015 Financial Results 5Global RNAi Market Report 2015-2024 - Technologies, Markets and Companies 2Global RNAi Market Report 2015-2024 - Technologies, Markets and Companies 3
... 2011 Misonix, Inc. (NASDAQ: MSON ... and markets innovative therapeutic ultrasonic products worldwide for ... surgery and other surgical and medical applications, announced ... Symposium on Advances in Skin and Wound Care ...
... Every year thousands of children are hospitalized — and ... (Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO) Teens share stolen prescription ... pills that look like candy. In this ... can prevent harm by locking your medicine up. ...
Cached Medicine Technology:Misonix Exhibits at 26th Annual Clinical Symposium on Advances in Skin and Wound Care 2Misonix Exhibits at 26th Annual Clinical Symposium on Advances in Skin and Wound Care 3
(Date:5/29/2015)... 29, 2015 The Global Allopurinol ... study on the current state of the Allopurinol ... key statistics on the state of the industry ... direction for companies and individuals interested in the ... the industry including definitions, classifications, applications and industry ...
(Date:5/29/2015)... (PRWEB) May 29, 2015 Designed with ... teamed up to create an all new, exclusive line ... a formulated with the latest and greatest, high impact, ... proven to be effective. The 24/7 Series can be ... cross-fitters and even the casual fitness enthusiasts. There are ...
(Date:5/29/2015)... May 29, 2015 Javlin continues to ... U.S. headquarters and a larger team, with the intention ... CloverETL's market share in the U.S. and Canada. , ... Group, achieved significant growth in 2014 with its strongest ... premier data integration platform, CloverETL. To accelerate further progress ...
(Date:5/29/2015)... 2015 This is a professional ... the Naproxen industry.The report provides a basic overview ... industry chain structure. The Naproxen market ... development trends, competitive landscape analysis, and key regions ... well as manufacturing processes and cost structures are ...
(Date:5/29/2015)... Michigan (PRWEB) May 29, 2015 Vulvodynia ... and can cause significant physical, sexual, and psychological distress. ... altering disorder of Vulvodynia. The actual diagnosis is often ... in Endometriosis, they realize that this problem can be ... experiencing any of these symptoms, they need to schedule ...
Breaking Medicine News(10 mins):Health News:Allopurinol Industry (Global, China) 2015 Research Analysis and 2020 Forecasts 2Health News:BPI Sports and Bodybuilding.com Partner Up to Bring an Innovative New Line of Supplements 2Health News:BPI Sports and Bodybuilding.com Partner Up to Bring an Innovative New Line of Supplements 3Health News:Growth of Data Integration Platform CloverETL Continues in North America 2Health News:Naproxen Market Analysis For Global & China Regions 2020 Research Forecasts 2
... ReauthorizationWASHINGTON, Jan. 14 The following fact sheet was ... the House: Divided We Fail Partnership (AARP, Business Roundtable, ... "On behalf of Divided We Fail, we urge you ... Children,s Health Insurance Program (SCHIP). Our nation has a ...
... journal report:Study highlights:-- Cholesterol-lowering drug adherence drops with ... of going for 90 straight days without medication ... all co-payment group and twice as high in ... to the exempt group (received prescriptions without a ...
... Utilize MICROSPONGE(R) Delivery SystemCARLSBAD, Calif., Jan. 14 ... Micro Wash, the only prescription benzoyl ... delivery system, for the treatment of mild ... Wash contains 7% benzoyl peroxide.(Photo: http://www.newscom.com/cgi-bin/prnh/20090114/LA58962 ...
... Rehab MarketHOUSTON, Jan. 14 Anne Kieschnik, a complex ... joined Alliance Seating & Mobility (ASM), one ... Kieschnik is an Assistive Technology Professional (ATP) ... for ASM ( www.alliance-seating.com ) and is responsible for ...
... access journal reportStudy highlights:, , ... odds of having cardiovascular disease within 10 years may not be ... Most adults 50 years and younger have a low 10-year risk ... disease. , Researchers suggest using ...
... blood-sucking critters, resistance to insecticides increasing in urban areas , , ... insecticides appears to be why bed bugs are making a ... , Bed bugs in New York City, where infestations have ... mutations that weaken the effect of the pyrethroid toxins, such ...
Cached Medicine News:Health News:Health Care For 11 Million Children 2Health News:Health Care For 11 Million Children 3Health News:Health Care For 11 Million Children 4Health News:Co-Payment Increases Result in Gaps in Veterans' Prescription Usage 2Health News:Co-Payment Increases Result in Gaps in Veterans' Prescription Usage 3Health News:Co-Payment Increases Result in Gaps in Veterans' Prescription Usage 4Health News:SkinMedica(R) Launches NeoBenz(R) Micro Wash for Acne 2Health News:SkinMedica(R) Launches NeoBenz(R) Micro Wash for Acne 3Health News:Veteran Rehab Specialist, Anne Kieschnik, Joins Fast-Growing Alliance Seating & Mobility In Texas 2Health News:Veteran Rehab Specialist, Anne Kieschnik, Joins Fast-Growing Alliance Seating & Mobility In Texas 3Health News:Half of Adults 50 and Younger With Low 10-Year Risk of CVD Have High Lifetime Risk 2Health News:Half of Adults 50 and Younger With Low 10-Year Risk of CVD Have High Lifetime Risk 3Health News:Bed Bugs, Nearly Eradicated, Make a Comeback 2
... vascular tests for assessing peripheral vascular disease. With the Portable ABI Kit, you get the basic equipment ... ... ... The ankle-arm pressure index (also known as the Ankle/Brachial ...
... Clinitek Microalbumin Strips provide albumin, creatinine ... The Clinitek Microalbumin product is useful to ... or hypertension in order to detect early ... elevation of the urinary albumin excretion rate, ...
... today's busy physician's office environment, ... contribute to timing errors and ... strips are read visually. Studies ... is performed with an instrument, ...
... Ultra device consists of a non-compliant balloon ... mounted longitudinally on its outer surface. When ... the atherotomes score the plaque, creating initiation ... to as Atherotomy, allows dilatation of the ...
Medicine Products: